|
CCDC126 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62536650805123E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63080660087189E-12 |
| Normal-vs-Stage2 |
1.58479995793215E-09 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.457180E-01 |
| Stage1-vs-Stage3 |
1.127730E-02 |
| Stage1-vs-Stage4 |
2.01820000000907E-06 |
| Stage2-vs-Stage3 |
3.882300E-03 |
| Stage2-vs-Stage4 |
1.184830E-04 |
| Stage3-vs-Stage4 |
5.355600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
7.42139999454494E-08 |
| Normal-vs-Asian |
4.84168261039031E-13 |
| Caucasian-vs-AfricanAmerican |
4.760600E-01 |
| Caucasian-vs-Asian |
2.851800E-01 |
| AfricanAmerican-vs-Asian |
9.044800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.88737914186277E-15 |
| Male-vs-Female |
2.721600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62858615482264E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62536650805123E-12 |
| Normal-vs-Age(81-100Yrs) |
1.393930E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.291400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.942200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.727000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.559800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.947200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.403200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.81309999999613E-05 |
| Classical-VS-Follicular |
1.008370E-04 |
| Classical-VS-Other |
9.409800E-01 |
| Classical-VS-Normal |
1.62625468647093E-12 |
| Tall-VS-Follicular |
1.0462000155087E-09 |
| Tall-VS-Other |
6.280400E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.900970E-01 |
| Follicular-VS-Normal |
6.56919962871427E-10 |
| Other-VS-Normal |
1.396350E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
8.097100E-03 |
|
|
